Before inspecting OmicsBraid outcomes, define the biological contrast, effect direction, ordered omic layers, inclusion/coverage rules, equivalence margin, trajectory margin, and multiplicity-control strategy.
Use assay-appropriate normalization/QC outside OmicsBraid. Preserve sample identifiers and genuine missingness.
fit <- run_omics_braid(
obj,
group = "group",
reference = "WT",
comparison = "Mutant",
omic_order = c("RNA", "Protein", "Phosphoprotein"),
bootstrap_B = 300,
bootstrap_shrinkage = 0.05,
ci_method = "analytic",
integrated_ci_method = "analytic",
equivalence_margin = 0.30,
trajectory_margin = 0.15,
pattern_draws = 1000,
seed = 1
)For targeted robustness checks, use subject-level permutation omnibus and null-shift bootstrap heterogeneity. Do not describe post-screening empirical results as independent genome-wide confirmation.
For key entities report layer-specific effects with intervals, GLS
consensus, omnibus evidence, Q_omics, braid pattern/status,
and any empirical sensitivity result. Avoid reporting a braid label
without the underlying effects.